This inventor holds 5 USPTO granted patents. Top assignees: Glaxo Wellcome Inc., Burroughs Wellcome Co., Other. Active years: 1982-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 281 
1 out of 521 
1 out of 834,601 Years Active: 1982-1999
Title: Gordon Lewis Hodgson, Jr.: A Pioneer in Hypolipidemic Research
Introduction
Gordon Lewis Hodgson, Jr. is a notable inventor based in Durham, NC (US), recognized for his significant contributions to the field of hypolipidemic research. With a total of five patents to his name, Hodgson has made strides in developing innovative compounds aimed at lowering lipid levels in the body.
Latest Patents
Hodgson's latest patents include groundbreaking work on hypolipidemic benzothiazepines and hypolipidaemic condensed 1,4-thiazepines. These inventions reflect his commitment to advancing medical science and improving health outcomes for individuals with lipid-related conditions.
Career Highlights
Throughout his career, Hodgson has worked with prominent organizations, including Glaxo Wellcome Inc. His experience in the pharmaceutical industry has allowed him to apply his research in practical settings, contributing to the development of effective treatments.
Collaborations
Hodgson has collaborated with esteemed colleagues such as Lawrence Edward Brieaddy and Anthony Louis Handlon. These partnerships have fostered a collaborative environment that has enhanced the quality and impact of his research.
Conclusion
Gordon Lewis Hodgson, Jr. stands out as a dedicated inventor whose work in hypolipidemic research has the potential to make a lasting impact on public health. His innovative patents and collaborations highlight his significant role in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile